DEXTER® Robotic Surgery System to Memorial Hermann Health System

Distalmotion announces that it completed the first US sale and delivery of the DEXTER Robotic Surgery System to Memorial Hermann Health System in Houston, Texas in early February. This milestone marks a significant step toward expanding access to robotic surgery in the United States. Distalmotion, a MedTech company with more than 1,500 surgical cases completed … Read more

Distalmotion Advances US Expansion of its DEXTER® Surgical Robot with Clinical Milestones and System Enhancements

Distalmotion, the global MedTech company empowering access to the benefits of robotic surgery, progresses on the path to expand its US footprint with the completion of cholecystectomy and benign hysterectomy clinical trials – to support 510(k) pre-market submissions for additional indications – and product enhancements to further increase procedural fluidity and wristed instrument dexterity. The … Read more

DEXTER® Robotic Surgery System by the First Ambulatory Surgery Center in the US

Two patients were treated for inguinal hernia repair using Distalmotion’s Dexter® Robotic Surgery System within 30 days of FDA De Novo Northtowns Ambulatory Surgery Center (ASC), a joint venture between Buffalo surgeons and Kaleida Health Ventures, has chosen Distalmotion’s DEXTER® Robotic Surgery System as its outpatient surgical robot of choice, marking a major milestone in … Read more

Dexter® Robotic Surgery System in the Outpatient Setting

Two patients were treated for inguinal hernia repair using Distalmotion’s Dexter® Robotic Surgery System within 30 days of FDA De Novo marketing authorization. Less than 30 days after receiving FDA De Novo marketing authorization, Distalmotion’s Dexter Robotic Surgery System has successfully treated the first US patients in an outpatient setting. Two adult inguinal hernia repairs … Read more

First Patients in U.S. Treated with Distalmotion’s Dexter Surgical Robot in the Outpatient Setting

October 28 , 2024 Distalmotion’s Dexter Surgical Robot opens an entire new era for soft tissue robotics in the outpatient setting and ambulatory surgery centers that will have immediate benefit for patients. ​​​ ​​​Distalmotion has been granted De Novo approval by the U.S. Food and Drug Administration (FDA) to market the Dexter Surgical Robot for … Read more

FDA Grants De Novo Marketing Authorization for the Distalmotion Dexter® Surgical Robot

October 28 , 2024 Distalmotion, a pioneer in surgical robotics, proudly announces the achievement of a significant milestone: surpassing 1000 successful procedures with its surgical robot, Dexter. Since its first commercial installation in 2022, Dexter has become a cornerstone in surgical innovation, treating patients everyday across multiple countries and institutions. ​​​ Distalmotion has been granted … Read more

Distalmotion Celebrates Milestone: Over 1000 Procedures Successfully Completed with the Surgical Robot Dexter®

May 15 , 2024 Distalmotion, a pioneer in surgical robotics, proudly announces the achievement of a significant milestone: surpassing 1000 successful procedures with its surgical robot, Dexter. Since its first commercial installation in 2022, Dexter has become a cornerstone in surgical innovation, treating patients everyday across multiple countries and institutions. This milestone underscores the maturity … Read more

With Proximie to Extend Surgical Excellence Globally

January 10, 2024 Distalmotion – a pioneer in surgical robotics, is partnering with Proximie, the leading global health technology platform digitizing operating rooms (ORs), to extend its ground-breaking Dexter® robotic surgery platform globally. The collaboration provides Distalmotion customers with access to Proximie’s healthcare platform, delivering telepresence, content management, and data driven insights. With Proximie, surgeon … Read more